These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 25582311)

  • 21. Volumetric bone mineral density of the spine predicts mortality in African-American men with type 2 diabetes.
    Lenchik L; Register TC; Russell GB; Xu J; Smith SC; Bowden DW; Divers J; Freedman BI
    Osteoporos Int; 2018 Sep; 29(9):2049-2057. PubMed ID: 29855664
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High serum sclerostin predicts the occurrence of osteoporotic fractures in postmenopausal women: the Center of Excellence for Osteoporosis Research Study.
    Ardawi MS; Rouzi AA; Al-Sibiani SA; Al-Senani NS; Qari MH; Mousa SA
    J Bone Miner Res; 2012 Dec; 27(12):2592-602. PubMed ID: 22836717
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Elevated sclerostin levels are associated with vertebral fractures in patients with type 2 diabetes mellitus.
    Yamamoto M; Yamauchi M; Sugimoto T
    J Clin Endocrinol Metab; 2013 Oct; 98(10):4030-7. PubMed ID: 23894157
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sclerostin is positively associated with bone mineral density in men and women and negatively associated with carotid calcified atherosclerotic plaque in men from the African American-Diabetes Heart Study.
    Register TC; Hruska KA; Divers J; Bowden DW; Palmer ND; Carr JJ; Wagenknecht LE; Hightower RC; Xu J; Smith SC; Dietzen DJ; Langefeld CD; Freedman BI
    J Clin Endocrinol Metab; 2014 Jan; 99(1):315-21. PubMed ID: 24178795
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased serum sclerostin and decreased serum IGF-1 are associated with vertebral fractures among postmenopausal women with type-2 diabetes.
    Ardawi MS; Akhbar DH; Alshaikh A; Ahmed MM; Qari MH; Rouzi AA; Ali AY; Abdulrafee AA; Saeda MY
    Bone; 2013 Oct; 56(2):355-62. PubMed ID: 23845326
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical and endocrine correlates of circulating sclerostin levels in patients with type 1 diabetes mellitus.
    Neumann T; Hofbauer LC; Rauner M; Lodes S; Kästner B; Franke S; Kiehntopf M; Lehmann T; Müller UA; Wolf G; Hamann C; Sämann A
    Clin Endocrinol (Oxf); 2014 May; 80(5):649-55. PubMed ID: 24237244
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum extracellular secreted antagonists of the canonical Wnt/β-catenin signaling pathway in patients with Cushing's syndrome.
    Belaya ZE; Rozhinskaya LY; Melnichenko GA; Solodovnikov AG; Dragunova NV; Iljin AV; Dzeranova LK; Dedov II
    Osteoporos Int; 2013 Aug; 24(8):2191-9. PubMed ID: 23358608
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Circulating sclerostin and estradiol levels are associated with inadequate response to bisphosphonates in postmenopausal women with osteoporosis.
    Morales-Santana S; Díez-Pérez A; Olmos JM; Nogués X; Sosa M; Díaz-Curiel M; Pérez-Castrillón JL; Pérez-Cano R; Torrijos A; Jodar E; Rio LD; Caeiro-Rey JR; Reyes-García R; García-Fontana B; González-Macías J; Muñoz-Torres M
    Maturitas; 2015 Dec; 82(4):402-10. PubMed ID: 26358930
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Linear and Non-linear Correlations Between Serum Phosphate Level and Bone Mineral Density in Type 2 Diabetes.
    Yang Y; Liu G; Zhang Y; Xu G; Yi X; Liang J; Zhao C; Liang J; Ma C; Ye Y; Yu M; Qu X
    Front Endocrinol (Lausanne); 2020; 11():497. PubMed ID: 32903642
    [No Abstract]   [Full Text] [Related]  

  • 30. Factors associated with bone mineral density and risk of fall in Korean adults with type 2 diabetes mellitus aged 50 years and older.
    Lee KM; Chung CY; Kwon SS; Lee SY; Kim TG; Choi Y; Park MS
    J Clin Endocrinol Metab; 2014 Nov; 99(11):4206-13. PubMed ID: 25140395
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Exploring the determinants of fracture risk among individuals with spinal cord injury.
    Lala D; Craven BC; Thabane L; Papaioannou A; Adachi JD; Popovic MR; Giangregorio LM
    Osteoporos Int; 2014 Jan; 25(1):177-85. PubMed ID: 23812595
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fibroblast Growth Factor-23, Sclerostin, and Bone Microarchitecture in Patients With Osteoporotic Fractures of the Proximal Femur: A Cross-sectional Study.
    Herlyn PK; Cornelius N; Haffner D; Zaage F; Kasch C; Schober HC; Mittlmeier T; Fischer DC
    J Clin Densitom; 2016; 19(2):192-201. PubMed ID: 25439456
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bone mineral density, bone turnover markers, and incident fractures in de novo kidney transplant recipients.
    Evenepoel P; Claes K; Meijers B; Laurent MR; Bammens B; Naesens M; Sprangers B; Pottel H; Cavalier E; Kuypers D
    Kidney Int; 2019 Jun; 95(6):1461-1470. PubMed ID: 30922664
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bone strength and muscle properties in postmenopausal women with and without a recent distal radius fracture.
    Crockett K; Arnold CM; Farthing JP; Chilibeck PD; Johnston JD; Bath B; Baxter-Jones AD; Kontulainen SA
    Osteoporos Int; 2015 Oct; 26(10):2461-9. PubMed ID: 26001559
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Distribution of bone density in the proximal femur and its association with hip fracture risk in older men: the osteoporotic fractures in men (MrOS) study.
    Yang L; Burton AC; Bradburn M; Nielson CM; Orwoll ES; Eastell R;
    J Bone Miner Res; 2012 Nov; 27(11):2314-24. PubMed ID: 22729872
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Measurement of cortical porosity of the proximal femur improves identification of women with nonvertebral fragility fractures.
    Ahmed LA; Shigdel R; Joakimsen RM; Eldevik OP; Eriksen EF; Ghasem-Zadeh A; Bala Y; Zebaze R; Seeman E; Bjørnerem Å
    Osteoporos Int; 2015 Aug; 26(8):2137-46. PubMed ID: 25876879
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relation between serum sclerostin and CTRP3 levels and bone mineral density in diabetic postmenopausal women.
    Ahmad IH; Elhamed Gbr SSA; Ali El Naggar BMM; Abdelwahab MK; El-Saghier EOA; Mohammed DS; Mohamed MA; Mohamed MS; Ali Abd El-Rahim MMM; Attar SE
    BMC Womens Health; 2024 Sep; 24(1):490. PubMed ID: 39237913
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Self-reported weight at birth predicts measures of femoral size but not volumetric BMD in eldery men: MrOS.
    Javaid MK; Prieto-Alhambra D; Lui LY; Cawthon P; Arden NK; Lang T; Lane NE; Orwoll E; Barrett-Conner E; Nevitt MC; Cooper C; Cummings SR;
    J Bone Miner Res; 2011 Aug; 26(8):1802-7. PubMed ID: 21509824
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Circulating levels of sclerostin are increased in patients with type 2 diabetes mellitus.
    García-Martín A; Rozas-Moreno P; Reyes-García R; Morales-Santana S; García-Fontana B; García-Salcedo JA; Muñoz-Torres M
    J Clin Endocrinol Metab; 2012 Jan; 97(1):234-41. PubMed ID: 22031520
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Proximal femoral density and geometry measurements by quantitative computed tomography: association with hip fracture.
    Cheng X; Li J; Lu Y; Keyak J; Lang T
    Bone; 2007 Jan; 40(1):169-74. PubMed ID: 16876496
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.